Gil J. van Lunsen, Director at ARRAY BIOPHARMA INC (ARRY), sold 21,500 shares at $13.92 ($299K) on 2018-08-15, disclosed to the SEC on 2018-08-17.
Open-market sale of $299k ARRY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ARRY | SELL | 2018-06-21 | $820K | — | Filing → |
| ARRY | SELL | 2018-05-17 | $330K | — | Filing → |
| ARRY | SELL | 2018-04-18 | $327K | — | Filing → |